Episode Details

Canada just made history by becoming the first G7 nation to approve a generic version of Ozempic, slashing drug costs by over two-thirds and offering hope to millions struggling with high prices for GLP-1 medications used to treat diabetes and weight management. While Canadians may see these affordable options in pharmacies by early June, Americans face years of steep prices—often over $1,000 monthly—due to extended patent protections. The move could spark a wave of cross-border drug shopping, reigniting debates over healthcare affordability and access across the border.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/9cf15b5347d4b821